Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken

Journal of Microbiology

Volumn 43, Issue 5, 2005, Pages 391-397

  Lee, Young Ju ^a   Cho, Jae Keun ^b   Kim, Ki Seuk ^a   Tak, Ryun Bin ^a   Kim, Ae Ran ^c   Kim, Jong Wan ^c   Im, Suk Kyoung ^c   Kim, Byoung Han ^c  

^a Kyungpook National University   (South Korea)

^b Daegu Metropolitan City Research Institute of Health and Environment   (South Korea)

^c Ministry of Agriculture and Forestry Korea   (South Korea)

Author keywords

E. coli; Fluoroquinolone resistance; gyrA gene; parC gene

Indexed keywords

ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; ARTICLE; CHICKEN; DRUG EFFECT; ESCHERICHIA COLI; FECES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION;

ANIMAL HUSBANDRY; ANIMALS; ANTI-INFECTIVE AGENTS; CHICKENS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION;

ANIMALIA; ESCHERICHIA COLI; XENOX;

EID: 27944479004     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aarestrup, F.M., Y. Agerso, P. Gerner-Smidt, M. Madsen, and L.B. Jensen. 2000. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn. Microbiol. Infect. Dis. 37, 127-37.
2. Amara, A., Z. Ziani, and K. Bouzoubaa. 1995. Antibiotic resistance of Escherichia coli strains isolated in Morocco from chickens with colibacillosis. Vet. Microbiol. 43, 325-330.
3. Bass, L., C.A. Liebert, M.D. Lee, A.O. Summers, D.G. White, S.G. Thayer, and J.J. Maurer. 1999. Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance, in avian Escherichia coli. Antimicrob. Agents Chemother. 43, 2925-2929.
4. Blanche, F., B. Cameron, F.X. Bernard, L. Maton, B. Manse, L., Ferrero, N. Ratet, C. Lecoq, A. Goniot, D. Bisch, and J. Crouzet. 1996. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob. Agents Chemother. 40, 2714-2720.
5. Bonten, M., E. Stobberingh, J. Philips, and A. Houben. 1990. High prevalence of antibiotic resistant Escherichia coli in faecal samples of students in the south-east of The Netherlands. J. Antimicrob. Chemother. 26, 585-592.
6. Cambau, F. and L. Gutmann. 1993. Mechanisms of resistance to quionolones. Drugs 45, 15-23.
7. Chin, S.C., N. Abdullah, T.W. Siang, and H.Y. Wan. 2005. Plasmid profiling and curing of Lactobacillus strains isolated from the gastrointestinal tract of chicken. J. Microbiol 43, 251-256.
8. Everett, M.J., Y.F. Jin, V. Ricci, and L.J. Piddock. 1996. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40, 2380-2386.
9. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a priv mary target of fluoroquinolones. Mol. Microbiol. 13, 641-653.
10. Han, H.S., H.Y. Nam, Y.J. Koh, J.S. Hur, and J.S. Jung. 2003. Molecular bases of high-level streptomycin resistance in Pseudomonas marginalis and Pseudomonas syringae pv. actinidiae. J. Microbiol. 41, 16-21.
11. Han, M.W. and T.H. Wood. 1969. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J. Bacteriol. 99, 238-241.
12. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40, 879-885.
13. Heisig, P., H. Schedletzdy, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 37, 696-701.
14. Hooper, D.C. 1995. Quinolone mode of action. Drugs. 49(Suppl. 2), 10-15.
15. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J. Kato, and H. Ikeda. 1994. Inhibition of quinolones against topoisomerase IV from Escherichia coli and comparison with the inhibitory potency against DNA gyrase. Antimicrob. Agents Chemother. 38, 2623-2627.
16. Kato, J., H. Suzuki, and H. Ikeda. 1992. Purification and characterization of DNA topoisomerase IV in Eshcherichia coli. J. Biol. Chem. 267, 25676-25684.
17. Khodursky, A.B. and Cozzarelli, N.R. 1998. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials. J. Biol. Chem. 274, 27668-27677.
18. Kumagai, Y., J.I. Kato, K. Hoshino, T. Akasaka, K. Sato, and H. Ikeda. 1996. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob. Agents Chemother. 40, 710-714.
19. Lagatolla, C., L. Dolzani, E. Tonin, A. Lavenia, M.D. Michele, T. Tommasini, and C. Monti-Bragadin. 1996. PCR ribotyping for characterizing Salmonella isolates of different serotypes. J. Clin. Microbiol. 34, 2440-2443.
20. Lee, Y.J., K.S. Kim, J.H. Kim, and R.B. Tak. 2004. Salmonella gallinarum gyrA mutations associated with fluoroquinolone resistance. Avian Pathol. 33, 251-257.
21. Lee, Y.J., K.S. Kim, Y.K. Kwon, and R.B. Tak. 2003. Biochemical characteristics and antimicrobials susceptibility of Salmonella gallinarum isolated in Korea. J. Vet. Sci. 4, 161-166.
22. Murray, B.E. 1990. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3, 46-65.
23. NCCLS. 2000. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard-fifth edition. M31-A.
24. Oram, M. and L.M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35, 387-389.
25. Peng, H. and K. Marians. 1993. Escherichia coli topoisomerase IV: purification, characterization, subunit structure, and subunit interactions. J. Biol. Chem. 268, 24481-24490.
26. Pinheiro, E.T., B.P.F.A. Gomes, D.B. Drucker, A.A. Zaia, C.C.R. Ferraz, and F.J. Souza-Filho. 2004. Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions. Int. Endo. J. 37, 756-763.
27. Prescott, J.F. and Baggot, J.D. 1993. Fluoroquinolones. p. 252-262. In Antimicrobial therapy in veterinary medicine, 2nd ed, Iowa State University Press, Ames, Iowa.
28. Quabdesselam, S., D.C. Hopper, J. Tankovic, and C.J. Soussy. 1995. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob. Agents Chemother. 39, 1667-1670.
29. Soussy, C.J., J.S. Wolfson, E.Y. Ng, and D.C. Hooper. 1993. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus. Antimicrob. Agents Chemother. 37, 2588-2592.
30. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34, 1271-1272.